The Single Nucleotide PolymorphismPPARG2Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients

Abstract

Background The PPARG2 Pro12Ala (rs1801282) and IL6 -174G >C (rs1800795) have important function in body weight regulation and a potential role in obesity risk. We aimed to investigate the association between PPARG2 Pro12Ala and IL6 -174G >C variants and the genotypes interaction with body composition, metabolic markers, food consumption, and physical activity in severely obese patients. Methods 150 severely obese patients (body mass index (BMI) ≥ 35 kg/m2) from Central Brazil were recruited. Body composition, metabolic parameters, physical activity, and dietary intake were measured. The genotype was determined by the qPCR TaqMan Assays System. Multiple linear regression and multiple logistic regression models were fitted adjusting for confounders. Results Ala carriers of the Pro12Ala polymorphism had higher adiposity measures (BMI: p=0.031, and fat mass: p=0.049) and systolic blood pressure (p=0.026) compared to Pro homozygotes. We found no important associations between the -174G >C polymorphism and obesity phenotypes. When genotypes were combined, individuals with genotypes ProAla + AlaAla and GC + CC presented higher BMI (p=0.029) and higher polyunsaturated fatty acids (PUFAs) consumption (p=0.045) compared to the ones with genotypes ProPro and GG, and individuals carriers of the PPARG2 Ala allele only (genotype ProAla + AlaAla and GG) had higher fat mass and systolic and diastolic blood pressure compared to the ones with genotypes ProPro and GG. Conclusions Severely obese individuals carrying the Ala allele of the PPARG2 Pro12Ala polymorphism had higher measures of adiposity and blood pressure, while no important associations were found for the IL6 -174G >C polymorphism.

Association of Pain, Severe Pain, and Multisite Pain with the Level of Physical Activity and Sedentary Behavior in Severely Obese Adults: Baseline Data from the DieTBra Trial

“…This study presents the baseline data of the clinical trial "DieTBra Trial," registered on the ClinicalTrials.gov platform (NCT02463435) [16][17][18]. The data collection was conducted between June 2015 and September 2016.…”

What are the factors associated with sarcopenia-related variables in adult women with severe obesity?

“…This study analyzes baseline data from the clinical trial "Effect of nutritional intervention and olive oil in severe obesity (DieTBra Trial)" [28] (project registered at Clini-calTrials.gov [NCT02463435]). Other results from this multidisciplinary clinical trial have already been published [29][30][31][32][33][34].…”

Bone Mineral Density in Severely Obese Women: Health Risk and Health Protective Risk Factors in Three Different Bone Sites

“…The data for this study are part of the baseline of a major randomized clinical trial called “Effect of nutritional intervention and olive oil in severe obesity-DieTBra Trial” [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]; details of the study design and subject recruitment and randomization are described in the literature [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]. Data collection was carried out at the Clinical Research Unit of the Faculty of Medicine Clinics Hospital, Federal University of Goiás, Brazil, between June 2015 and February 2016 [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]. The following eligibility criteria were adopted: women, aged between 18 and 64 years with a BMI ≥ 35 kg/m 2 and weight ≤ 130 kg.…”